|
1
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011.PubMed/NCBI
|
|
2
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: the implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aguda BD, Kim Y, Piper-Hunter MG, Friedman
A and Marsh CB: MicroRNA regulation of a cancer network:
consequences of the feedback loops involving miR-17–92, E2F, and
Myc. Proc Natl Acad Sci USA. 105:19678–19683. 2008.PubMed/NCBI
|
|
4
|
Xu TP, Zhu CH, Zhang J, et al:
MicroRNA-155 expression has prognostic value in patients with
non-small cell lung cancer and digestive system carcinomas. Asian
Pac J Cancer Prev. 14:7085–7090. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang S, Li Y, Gao J, et al: MicroRNA-34
suppresses breast cancer invasion and metastasis by directly
targeting Fra-1. Oncogene. 32:4294–4303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hulf T, Sibbritt T, Wiklund ED, et al:
Epigenetic-induced repression of microRNA-205 is associated with
MED1 activation and a poorer prognosis in localized prostate
cancer. Oncogene. 32:2891–2899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Chen X, Lian H, et al:
MicroRNA-503 acts as a tumor suppressor in glioblastoma for
multiple antitumor effects by targeting IGF-1R. Oncol Rep.
31:1445–1452. 2014.PubMed/NCBI
|
|
8
|
Zhang N, Li X, Wu CW, et al: microRNA-7 is
a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saydam O, Senol O, Würdinger T, et al:
miRNA-7 attenuation in Schwannoma tumors stimulates growth by
upregulating three oncogenic signaling pathways. Cancer Res.
71:852–861. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiong SD, Yu K, Liu XH, et al:
Ribosome-inactivating proteins isolated from dietary bitter melon
induce apoptosis and inhibit histone deacetylase-1 selectively in
premalignant and malignant prostate cancer cells. Int J Cancer.
125:774–782. 2009. View Article : Google Scholar
|
|
12
|
Zheng Y, Xiong S, Jiang P, et al:
Glucocorticoids inhibit lipopoly-saccharide-mediated inflammatory
response by downregulating microRNA-155: a novel anti-inflammation
mechanism. Free Radic Biol Med. 52:1307–1317. 2012. View Article : Google Scholar
|
|
13
|
Qiu ZX, Wang L, Han J, et al: Prognostic
impact of Raf-1 and p-Raf-1 expressions for poor survival rate in
non-small cell lung cancer. Cancer Sci. 103:1774–1779. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mukherjee R, Bartlett JM, Krishna NS,
Underwood MA and Edwards J: Raf-1 expression may influence
progression to androgen insensitive prostate cancer. Prostate.
64:101–107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aurora AB, Mahmoud AI, Luo X, et al:
MicroRNA-214 protects the mouse heart from ischemic injury by
controlling Ca2+ overload and cell death. J Clin Invest.
122:1222–1232. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khoshnaw SM, Green AR, Powe DG and Ellis
IO: MicroRNA involvement in the pathogenesis and management of
breast cancer. J Clin Pathol. 62:422–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Andorfer CA, Necela BM, Thompson EA and
Perez EA: MicroRNA signatures: clinical biomarkers for the
diagnosis and treatment of breast cancer. Trends Mol Med.
17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong C, Yao Y, Wang Y, et al:
Up-regulation of miR-21 mediates resistance to trastuzumab therapy
for breast cancer. J Biol Chem. 286:19127–19137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chan LW, Wang FF and Cho WC: Genomic
sequence analysis of EGFR regulation by microRNAs in lung cancer.
Curr Top Med Chem. 12:920–926. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kefas B, Godlewski J, Comeau L, et al:
microRNA-7 inhibits the epidermal growth factor receptor and the
Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reddy SD, Ohshiro K, Rayala SK and Kumar
R: MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase
1 and regulates its functions. Cancer Res. 68:8195–8200. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiong S, Zheng Y, Jiang P, et al:
PA28gamma emerges as a novel functional target of tumour suppressor
microRNA-7 in non-small-cell lung cancer. Br J Cancer. 110:353–362.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chou YT, Lin HH, Lien YC, et al: EGFR
promotes lung tumorigenesis by activating miR-7 through a
Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor
ERF. Cancer Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Navolanic PM, Steelman LS and McCubrey JA:
EGFR family signaling and its association with breast cancer
development and resistance to chemotherapy (Review). Int J Oncol.
22:237–252. 2003.PubMed/NCBI
|
|
27
|
Sonnweber B, Dlaska M, Skvortsov S,
Dirnhofer S, Schmid T and Hilbe W: High predictive value of
epidermal growth factor receptor phosphorylation but not of
EGFRvIII mutation in resected stage I non-small cell lung cancer
(NSCLC). J Clin Pathol. 59:255–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mukohara T, Kudoh S, Yamauchi S, et al:
Expression of epidermal growth factor receptor (EGFR) and
downstream-activated peptides in surgically excised non-small-cell
lung cancer (NSCLC). Lung Cancer. 41:123–130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bozzetti C, Tiseo M, Lagrasta C, et al:
Comparison between epidermal growth factor receptor (EGFR) gene
expression in primary non-small cell lung cancer (NSCLC) and in
fine-needle aspirates from distant metastatic sites. J Thorac
Oncol. 3:18–22. 2008. View Article : Google Scholar
|
|
30
|
Lee KM, Choi EJ and Kim IA: microRNA-7
increases radiosensitivity of human cancer cells with activated
EGFR-associated signaling. Radiother Oncol. 101:171–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kalinowski FC, Giles KM, Candy PA, et al:
Regulation of epidermal growth factor receptor signaling and
erlotinib sensitivity in head and neck cancer cells by miR-7. PLoS
One. 7:e470672012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duex JE, Comeau L, Sorkin A, Purow B and
Kefas B: Usp18 regulates epidermal growth factor (EGF) receptor
expression and cancer cell survival via microRNA-7. J Biol Chem.
286:25377–25386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Webster RJ, Giles KM, Price KJ, Zhang PM,
Mattick JS and Leedman PJ: Regulation of epidermal growth factor
receptor signaling in human cancer cells by microRNA-7. J Biol
Chem. 284:5731–5741. 2009. View Article : Google Scholar : PubMed/NCBI
|
